Hofer & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$297K Buy
1,215
+25
+2% +$5.82K 0.16% 50
2025
Q4
$246K Hold
1,190
0.13% 59
2025
Q3
$221K Sell
1,190
-200
-14% -$34.3K 0.13% 59
2025
Q2
$212K Sell
1,390
-518
-27% -$79.6K 0.13% 53
2025
Q1
$316K Buy
1,908
+13
+0.7% +$2.03K 0.21% 46
2024
Q4
$274K Sell
1,895
-278
-13% -$43.1K 0.18% 49
2024
Q3
$352K Sell
2,173
-37
-2% -$5.89K 0.24% 40
2024
Q2
$323K Sell
2,210
-27
-1% -$4.02K 0.25% 39
2024
Q1
$354K Sell
2,237
-27
-1% -$4.3K 0.3% 38
2023
Q4
$355K Buy
2,264
+264
+13% +$40.5K 0.33% 37
2023
Q3
$311K Buy
2,000
+45
+2% +$7.42K 0.32% 37
2023
Q2
$324K Buy
1,955
+55
+3% +$8.88K 0.31% 38
2023
Q1
$336K Hold
1,900
0.34% 35
2022
Q4
$336K Sell
1,900
-9
-0.5% -$1.55K 0.33% 35
2022
Q3
$312K Sell
1,909
-107
-5% -$18.1K 0.34% 36
2022
Q2
$358K Buy
2,016
+40
+2% +$7.13K 0.37% 32
2022
Q1
$350K Sell
1,976
-10
-0.5% -$1.7K 0.31% 39
2021
Q4
$340K Buy
+1,986
New +$325K 0.31% 39

Other funds holding JNJ

Hofer & Associates's JNJ Position: Q1 2026 in Review

Hofer & Associates increased its Johnson & Johnson (JNJ) stake by 2.1% in Q1 2026, buying an estimated $5.82K and bringing the position to 1,215 shares worth $297K. The position accounts for 0.16% of the portfolio, ranked #50.

Hofer & Associates first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $358K in Q2 2022. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Hofer & Associates held 1,215 shares of Johnson & Johnson worth $297K as of Q1 2026.
  • Hofer & Associates bought 25 Johnson & Johnson shares in Q1 2026, an estimated $5.82K.
  • Johnson & Johnson made up 0.16% of Hofer & Associates's portfolio in Q1 2026, its #50 holding.
  • Hofer & Associates first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • Hofer & Associates's Johnson & Johnson position peaked at $358K in Q2 2022.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Hofer & Associates's 13F filing for Q1 2026, filed 22 Apr 2026.